|
Volumn 15, Issue 20, 2007, Pages 6556-6564
|
5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H- pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist
|
Author keywords
Non steroidal; PR agonists; PR antagonists; Progesterone receptor (PR)
|
Indexed keywords
1 CYCLOPENTYL 6 (3,4 DIFLUOROPHENYL) 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
1 CYCLOPENTYL 6 (3,4 DIFLUOROPHENYL) 1,3 DIHYDRO 2H BENZIMIDAZOLE 2 THIONE;
3 (3 CYCLOBUTYL 2 OXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL) 5 FLUOROBENZONITRILE;
3 (3 CYCLOBUTYL 2 THIOXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 FLUOROBENZONITRILE;
3 [3 (1 ETHYLPROPYL) 2 OXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL] 5 FLUOROBENZONITRILE;
3 [3 (1 ETHYLPROPYL) 2 THIOXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL] 5 FLUOROBENZONITRILE;
5 (3 CYCLOBUTYL 2 OXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL) 1 METHYL 1H PYRROLE 2 CARBONITRILE;
5 (3 CYCLOBUTYL 2 THIOXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL) 1 METHYL 1H PYRROLE 2 CARBONITRILE;
5 (3 CYCLOPENTYL 2 OXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL) 1 METHYL 1H PYRROLE 2 CARBONITRILE;
5 (3 CYCLOPENTYL 2 THIOXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL) 1 METHYL 1H PYRROLE 2 CARBONITRILE;
5 [3 (1 ETHYLPROPYL) 2 OXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL] 1 METHYL 1H PYRROLE 2 CARBONITRILE;
5 [3 (1 ETHYLPROPYL) 2 THIOXO 2,3 DIHYDRO 1H BENZIMIDAZOL 5 YL] 1 METHYL 1H PYRROLE 2 CARBONITRILE;
6 (3 CHLORO 4 FLUOROPHENYL) 1 (1 ETHYLPROPYL) 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
6 (3 CHLORO 4 FLUOROPHENYL) 1 (1 ETHYLPROPYL) 1,3 DIHYDRO 2H BENZIMIDAZOLE 2 THIONE;
6 (3 CHLORO 4 FLUOROPHENYL) 1 CYCLOPENTYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
6 (3 CHLORO 4 FLUOROPHENYL) 1 CYCLOPENTYL 1,3 DIHYDRO 2H BENZIMIDAZOLE 2 THIONE;
6 BROMO 1 (1 ETHYLPROPYL) 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
6 BROMO 1 CYCLOBUTYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
6 BROMO 1 CYCLOPENTYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE;
ALKALINE PHOSPHATASE;
ANDROGEN RECEPTOR;
COMPLEMENT COMPONENT C3;
ETHINYLESTRADIOL;
GLUCOCORTICOID;
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
PROGESTERONE;
PROGESTERONE DERIVATIVE;
PROGESTERONE RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DECIDUALIZATION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SYNTHESIS;
ENZYME ASSAY;
FEMALE;
HUMAN;
HUMAN CELL;
MONKEY;
NONHUMAN;
OVULATION;
RAT;
ADMINISTRATION, ORAL;
ALKALINE PHOSPHATASE;
ANIMALS;
CELL LINE, TUMOR;
FEMALE;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
NITRILES;
PYRROLES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, PROGESTERONE;
STEROIDS;
RATTUS;
|
EID: 34548185186
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2007.07.011 Document Type: Article |
Times cited : (24)
|
References (27)
|